The UK and the EU have not been able to reach a compromise on a trade deal, despite high-level negotiations.
Even an emergency flight to Brussels by British Prime Minister Boris Johnson was unable to facilitate progress in trade negotiations with the EU. The parties still have insurmountable differences, which nullify the parties’ chances of reaching an agreement.
The US has taken a step towards the beginning of vaccination against COVID-19. FDA advisers overwhelmingly approved Pfizer’s COVID-19 vaccine for emergency use.
JP Morgan predicts an increase in demand for Bitcoin as an alternative to gold. According to the bank’s strategists, the interest of funds in cryptocurrency is growing. However, the Bitcoin quotes failed to exceed the psychological target of $20,000.
Oil behaved unexpectedly contradictory. After the OPEC+ countries agreed to increase the volume of production of raw materials, and the reserves of black gold in the United States increased immediately by 15 million barrels, oil quotes could collapse. But the fragile peace continued and the Brent grade at the moment crossed the psychological mark of $50.
Future US President Joe Biden has nominated Katherine Tai, an Asian American known for her condemnation of Trump’s defensive tactics in relations with the PRC, to the post of trade representative.
A fundamental view
|The board of directors adopted the company last week made an important decision providing for the buyback of shares for $8 billion. Recall that the company is now completing the previous buyback program for $6.5 billion. We also add that the corporation has increased its dividend by 21%, which should attract investors.|
|Boeing continues to be one of the stocks that investors continue to avoid. Why? Despite news of the development of vaccines for COVID-19, countries are not ready to resume full-fledged flights. However, Airbnb recently had a successful IPO. And this can be a signal that the situation is stabilizing.|
Johnson & Johnson
|The Mexican government plans to order an additional 22 million doses of COVID-19 vaccine from Johnson & Johnson. It is noted that the cost of this vaccine will be half that of the Pfizer drug.|